Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMLODIPINE | 5.0MG | TABLET | Resolved | 2020-07-23 | 2020-08-07 | 120979 |
| APO-AMLODIPINE | 10MG | TABLET | Resolved | 2021-07-23 | 2021-08-23 | 142970 |
| APO-AMLODIPINE | 5MG | TABLET | Resolved | 2021-08-16 | 2021-09-07 | 144198 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 40MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 33 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2017-06-08 | 2017-08-08 | 12278 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 20MG | TABLET | Resolved | 2017-07-11 | 2017-08-08 | 15420 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2017-08-14 | 2017-10-24 | 19213 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2018-01-31 | 2018-07-03 | 37717 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 10MG | TABLET | Resolved | 2018-02-01 | 2018-07-03 | 37945 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2019-02-13 | 2019-04-22 | 75608 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2019-02-13 | 2019-04-22 | 75641 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2019-12-12 | 2020-01-15 | 101082 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2019-12-12 | 2020-01-22 | 101088 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119677 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 40MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119683 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119687 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 80MG | TABLET | Resolved | 2020-07-08 | 2020-07-13 | 119690 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2021-01-29 | 2021-05-26 | 132703 |
| APO-AMLODIPINE-ATORVASTATIN | 5MG 40MG | TABLET | Resolved | 2021-04-23 | 2021-05-26 | 137956 |
| APO-AMLODIPINE-ATORVASTATIN | 10MG 10MG | TABLET | Resolved | 2021-05-07 | 2021-05-26 | 138951 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |